{"id":5059,"date":"2018-08-10T10:31:35","date_gmt":"2018-08-10T10:31:35","guid":{"rendered":"http:\/\/mirth0\/en\/?page_id=5059"},"modified":"2025-07-23T15:55:20","modified_gmt":"2025-07-23T15:55:20","slug":"digestive-cancer","status":"publish","type":"page","link":"https:\/\/imas12.es\/en\/research\/cancer\/digestive-cancer\/","title":{"rendered":"Gastrointestinal and neuroendocrine tumors"},"content":{"rendered":"<p>The main lines of work of this research group are focused on:<\/p>\n<p>1) The molecular characterization of digestive neoplasms, with particular interest in colorectal cancer and neuroendocrine gastroenteropancreatic neoplasms.<\/p>\n<p>2) The development of new drugs or therapeutic strategies to treat these tumors.<\/p>\n<p>The <strong>specific goals<\/strong> of the research lines of this group are the following:<\/p>\n<ul>\n<li>To identify prognostic and\/or predictive response markers to specific antineoplastic therapies.<\/li>\n<li>To study drug resistance mechanisms.<\/li>\n<li>To identify new targets of potential diagnostic and\/or therapeutic interest.<\/li>\n<li>To carry out phase I-III clinical trials concerning the use of new drugs or therapeutic strategies in digestive tumors.<\/li>\n<\/ul>\n<p>In the field of <strong>hereditary cancer<\/strong>, this research group focuses primarily on the following aspects:<\/p>\n<ul>\n<li>Researching hereditary cancer to identify new genes, mutational signatures and biomarkers of risk prediction.<\/li>\n<li>Implementing novel massive sequencing techniques and other advanced genomic techniques in the screening and diagnosis of hereditary cancer.<\/li>\n<li>Providing technical support to oncological projects involving the use of massive sequencing techniques.<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>The main lines of work of this research group are focused on: 1) The molecular characterization of digestive neoplasms, with particular interest in colorectal cancer and neuroendocrine gastroenteropancreatic neoplasms. 2) The development of new drugs or therapeutic strategies to treat&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":24,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"research-group.php","meta":{"footnotes":""},"class_list":["post-5059","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/imas12.es\/en\/wp-json\/wp\/v2\/pages\/5059","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/imas12.es\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/imas12.es\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/imas12.es\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/imas12.es\/en\/wp-json\/wp\/v2\/comments?post=5059"}],"version-history":[{"count":3,"href":"https:\/\/imas12.es\/en\/wp-json\/wp\/v2\/pages\/5059\/revisions"}],"predecessor-version":[{"id":6125,"href":"https:\/\/imas12.es\/en\/wp-json\/wp\/v2\/pages\/5059\/revisions\/6125"}],"up":[{"embeddable":true,"href":"https:\/\/imas12.es\/en\/wp-json\/wp\/v2\/pages\/24"}],"wp:attachment":[{"href":"https:\/\/imas12.es\/en\/wp-json\/wp\/v2\/media?parent=5059"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}